Metabiomics Corp

This study aims to see how well a new stool test, called LifeKit Prevent, can detect colorectal cancer and precancerous growths (adenomas). About 12,000 adults aged 40 and older scheduled for a screening colonoscopy will provide a stool sample for the test. The results will be co…

This study was designed to see how often the Metabiomics stool test fails to detect colon cancer in people already diagnosed and awaiting surgery. No one was enrolled because the study was withdrawn. The goal was to measure the test's false negative rate.